Agios Pharmaceuticals, Inc. (AGIO) financial statements (2021 and earlier)

Company profile

Business Address 88 SIDNEY STREET
CAMBRIDGE, MA 02139
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:671722794613718541624
Cash and cash equivalents12710529689818284
Short-term investments445501494440484  
Other undisclosed cash, cash equivalents, and short-term investments98117484153459540
Receivables(1)(1)(1)(1)(1)(1)(0)
Inventory, net of allowances, customer advances and progress billings15111110765
Inventory15111110765
Contract with customer, asset21191212977
Other undisclosed current assets(69)(83)29(47)(122)(63)(102)
Total current assets:637669846587612490534
Noncurrent Assets
Finance lease, right-of-use asset11111  
Operating lease, right-of-use asset85878991949699
Property, plant and equipment32333434312423
Long-term investments and receivables98117485153  
Long-term investments98117485153  
Other noncurrent assets1122   
Other undisclosed noncurrent assets     89129
Total noncurrent assets:216239130212279208250
TOTAL ASSETS:853908976800891699784
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities87635758756865
Accounts payable27131519222215
Accrued liabilities60504240534749
Deferred revenue   5111718
Debt0006776
Deferred rent credit   0   
Other undisclosed current liabilities777    
Total current liabilities:94706470939290
Noncurrent Liabilities
Long-term debt and lease obligation98100102104107108110
Finance lease, liability00  1  
Operating lease, liability97100102104106108110
Liabilities, other than long-term debt  01515052
Deferred revenue    515052
Deferred rent credit  01   
Other undisclosed noncurrent liabilities164158251    
Total noncurrent liabilities:262358353105157158162
Total liabilities:453428418174250250251
Stockholders' equity
Stockholders' equity attributable to parent400480558625641448533
Common stock0000000
Additional paid in capital2,2432,2262,2042,1822,1561,8621,840
Accumulated other comprehensive income0120000
Accumulated deficit(1,843)(1,746)(1,647)(1,556)(1,516)(1,414)(1,308)
Total stockholders' equity:400480558625641448533
TOTAL LIABILITIES AND EQUITY:853908976800891699784

Income statement (P&L) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Revenues44353787352626
Cost of revenue
(Cost of Goods and Services Sold)
(1)(1)(1)(1)(0)(0)(0)
Gross profit:43343787352626
Operating expenses(136)(124)(127)(130)(140)(135)(140)
Other undisclosed operating income (loss)    (1)00
Operating loss:(92)(90)(90)(43)(106)(109)(114)
Nonoperating income
(Investment Income, Nonoperating)
1123434
Other undisclosed loss from continuing operations before equity method investments, income taxes(18)      
Net loss:(110)(89)(88)(40)(102)(106)(110)
Other undisclosed net income (loss) attributable to parent12(10)(2)    
Net loss available to common stockholders, diluted:(98)(99)(90)(40)(102)(106)(110)

Comprehensive Income ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Net loss:(110)(89)(88)(40)(102)(106)(110)
Other comprehensive income (loss) (1)2(0) (0)1
Comprehensive loss:(110)(90)(87)(40)(102)(106)(109)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent11(10)(2) (0)  
Comprehensive loss, net of tax, attributable to parent:(98)(100)(89)(40)(103)(106)(109)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: